The Effect of Therapy Combination in PCOS With Dlbs 3233
Recruiting
Early Phase 1
Interventional Study
Polycystic Ovary Syndrome
No Placebo Group
Every participant receives an active treatment — no one gets a placebo.
At a Glance
- Age
- Up to 45
- Sex
- Female
- Trial phase
- Early Phase 1
- Study type
- Interventional
- Purpose
- Treatment
- Participants needed
- 90 (estimated)
- Sponsor
- Inlacinpenelitian · Other
Think this trial could be right for you?
Answer a few quick questions to see if you may meet the eligibility requirements.
Check Your Eligibility
About This Trial
The effect of combination therapy dlbs 3233 and clomifen citrate vs clomifen citrate on homa ir, maturation follicle, and menstrual cycle in PCOS cases at Muhammadiyah Asri Medical Center Hospital
Trial Locations
Loading…
Loading trial locations…
Eligibility Criteria
Inclusion Criteria:
* married agree to join this research
Exclusion Criteria:
* dis agree to join research
Contacts